Marketing-authorisation holder
Panpharma
3 medicines in 1 country, as authorisation holder.
Loading…
Marketing-authorisation holder
3 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Dexamethasonfosfaat Panpharma 4 mg/ml, oplossing voor injectieOplossing voor injectie | Dexamethasone | Netherlands | Authorised | 2025 |
| Pankaine Glucose 5 mg/ml, oplossing voor injectieOplossing voor injectie | Bupivacaine | Netherlands | Authorised | 2019 |
| Suxamethoniumchloride Panpharma 50 mg/ml oplossing voor injectie/infusieOplossing voor injectie of infusie | Suxamethonium | Netherlands | Authorised | 2023 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 3 | 3 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
Keep Panpharma’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callOther companies in the same group.